Need assistance?
Key takeaways:
- Bretton Lane, BS, RPSGT, has been named president and chief growth officer.
- She previously served as president of BetterNight, guiding the company’s expansion from approximately 20 employees to nearly 450.
- In her new role, she will help expand home sleep testing capabilities, evaluate emerging technologies, and strengthen strategic partnerships.
Persante Health Care has named Bretton Lane, BS, RPSGT, as its new president and chief growth officer. She joins the executive leadership team as the organization continues expanding its sleep management services and supporting hospitals, health systems, physician practices, and sleep centers nationwide.
Most recently, Lane served as president of BetterNight, where she helped guide the company’s expansion from approximately 20 employees to nearly 450. During her tenure, she oversaw operations spanning sleep diagnostics, virtual care, durable medical equipment, dental sleep medicine, and population health initiatives.
“We’re excited to welcome Bretton to Persante,” says Vyto Kab, CEO of Persante, in a release. “She brings exceptional industry knowledge, proven leadership, and a passion for advancing sleep medicine. Bretton is joining an already exceptional management team, and we’re confident her experience will strengthen our organization, support our partners, and help build on the momentum we’ve created.”
“Choosing the right opportunity mattered, and that’s why Persante stood out. Joining one of the largest sleep management companies in the country, with a strong foundation, an exceptional team, and a clear vision for the future, made this an exciting next step in my career,” says Lane, in a release. “With so much happening across the sleep industry, Persante is uniquely positioned to help shape what’s next, and I’m excited to be part of that journey.”
As president and chief growth officer, Lane will help expand Persante’s home sleep testing capabilities, support the development of new programs and services, and strengthen strategic partnerships. She will also evaluate emerging technologies that enhance operational performance while reinforcing a commitment to clinical excellence, regulatory compliance, patient privacy, and patient care.
More in Persante:
Advertisement
